Kayla Leathem
Pharmacist
3500 Gaston Ave, Dallas
Texas, 75246-2088
214-820-8116 Kayla Leathem is a pharmacist in Dallas, Texas. Patients can reach her at 3500 Gaston Ave, Dallas or contact her on 214-820-8116. Active license number of Kayla Leathem is 72679 for Pharmacist in Texas.
Kayla Leathem is
Complete Profile:
Kayla Leathem speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | Kayla Leathem |
| Specialization: | Pharmacist |
| Credentials: | PHARMD |
| Gender: | Female |
| Location: | 3500 Gaston Ave, Dallas,
Texas, 75246-2088 |
| Phone: | 214-820-8116 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kayla Leathem are as mentioned below.
| NPI Number: | 1679336457 |
| NPI Enumeration Date: | 05 Feb, 2024 |
| NPI Last Update On: | 05 Feb, 2024 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kayla Leathem are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | 72679 | Texas | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 5490 Denton Drive Cut Off Apt 2304,
Dallas, Texas |
| Zip: | 75235-7645 |
| Phone Number: | 504-330-1027 |
Patients can reach Kayla Leathem at
3500 Gaston Ave, Dallas, Texas or can
call on phone at 214-820-8116.
Comments/ Reviews:
Read all the reviews posted for Kayla Leathem below. You may also share your own experience with Kayla Leathem. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.